Major Pharma Players in-house CDMO Capabilities
10 - 11 September 2025 | Sheraton Towers Singapore
For deeper engagement, join us at BCDMOA 2025 in Singapore, where collaboration and innovation shape the future of biologics manufacturing.
BIOLOGICS CDMO ASIA 2025
Asia's Premier Event Exclusively for CDMO's!
📍Sheraton Towers Singapore 📆 10 - 11 September 2025
The 4th Biologics CDMO Asia 2025 is a prominent event that brings together key leaders in the contract manufacturing sector to exchange successful case studies, address challenges and opportunities, and explore potential partnerships. It is also the only conference in the region that is exclusively focused on Contract Manufacturing in the APAC region.
350+ Attendees
180+ Organisations
40+ Expert Speakers
2025 SPEAKERS
Christopher Pawlak
External Manufacturing Lead, Bayer, Switzerland
Daniel Hurni
Former Director Manufacturing Network Strategy and Business Intelligence, Bristol Myers Squibb, Switzerland
Hu Jun
Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, Singapore
Sudeep Srivastava
Senior Vice President, Biological E. Limited, India
Jimmy Chang
CEO, TaiMed Biologics, Taiwan
Julio Lin
Vice President, Blue Blood Biotech, Taiwan
Jennifer Kuan
VP of Taiwan Operations, Bora Biologics, Taiwan
Kamyar Sadri
Former Regional Digital, Data & IT Lead, South East Asia, Novo Nordisk, Singapore
Warren Chan
Dean of the College of Engineering, Nanyang Technological University (NTU), Singapore
Lucas Chan
Visiting Senior Investigator and Advisor, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Bi Xuezhi
Senior Principal Scientist I & Group Leader, Protein Analytics, A*STAR Bioprocessing Technology Institute (BTI), Singapore
Andy Tan
Principal Scientist and Group Leader, Immune Cell Manufacturing, A*STAR Bioprocessing Technology Institute (BTI), Singapore
Zach Pang
Group Leader, Analytical Science & Technology (Bioprocess Data Integration), A*STAR Bioprocessing Technology Institute (BTI), Singapore
Akhil Prakash Chincholikar
Head R&D Project Management, Naprod Life Sciences, India
Andrew Bruce
Chief Executive Officer, Medisix Therapeutics, Singapore
Antonio Lee
CEO and Managing Director, MEDIPOST, South Korea
Chethan Jaiprakash
Assistant Director – QA & Regulatory Affairs, Center for Ocular Regeneration at LV Prasad Eye Institute, India
Cecilia Zhang
Chief Scientific Officer, Biosyngen, Singapore
Cheng-Yi Jerry Kuo
Vice General Manager, UWELL Biopharma, Taiwan
Cyrus Yang
CEO, Taiwan Bio Therapeutics, Taiwan
Deborah Rathjen
Chief Executive Officer, Carina Biotech, Australia
Dinesh Kundu
Director & Co-Founder, East Ocyon Bio, India
Francesca Lim
Head, Singhealth Duke NUS Cell Therapy Center, Singapore
Ian Nisbet
Chief Operating Officer, Cartherics, Australia
Ivan Horak
Founder and CEO, Tikva Allocell, Singapore
Kerwin Kwek Zeming
Research Scientist, Singapore-MIT Alliance for Research & Technology Centre, Singapore
Lu-En Wai
Senior Director of Research & Development, Lion TCR, Singapore
Maloy Ghosh
CSO, Zumutor Biologics, India
Paula Lam
Chief Scientific Officer, BioCell Innovations, Singapore
Ramin Baghirzade
Global Head Commercial – Cell & Gene Therapy CDMO Services, Charles River
Ranga Prakash
Director Medical Affairs, Southeast Asia, Miltenyi Biomedicine, Singapore
Rebecca McQualter
Chief Executive Officer, Chimeric Therapeutics, Australia
Richard Wang
Founder & CEO, Neukio Biotherapeutics, China
Rosanne Dunn
Director & Chief Scientific Officer, HaemaLogiX, Australia
Ryuichi Morishita
Chief Section of Gene Therapy, Department of Geriatric Medicine, Osaka University, Japan
Sacha Khong
Head of MSAT, CGT, Lonza Bioscience, Singapore
Sandy Qlintang
President Director, Bifarma Adiluhung, Indonesia
Sheng Rong Ng
Senior Scientist, Nuevocor, Singapore
Siang-Chueng Koo
Director, J&J Regulatory Compliance (Innovative Medicine), Asia Pacific, Johnson & Johnson, Singapore
Supannikar (Fai) Tawinwung
Facility Director, Chulalongkorn University, Thailand
Udaykumar Kolkundkar
Senior Vice President – Technical Operations, Stempeutics Research, India
Wei-Kai Hua
Project Manager, R&D, GenomeFrontier Therapeutics, Taiwan
Yan Xiaojun
CTO, CytoNiche Biotech, Singapore
Yen Choo
Associate Professor of Stem Cell Science and Regenerative Medicine, Lee Kong Chian School of Medicine, Singapore
Nora Pataut
Innovation & Manufacturing Technologies Program Manager, GSK, Singapore
Share With Your Network
